Continuous Variables in Responding and Nonresponding Patients
| Variable . | Responding Patients, n = 18 . | Nonresponding Patients, n = 29 . | P Value . |
|---|---|---|---|
| Age (yr) | 70 ± 10 | 68 ± 10 | .6 |
| Disease duration (mo) | 10 ± 11 | 9 ± 10 | .74 |
| RBC transf. units/mo* | 2.0 ± 0.94 | 3.0 ± 1.4 | .05 |
| Hemoglobin level (g/dL) | 88.6 ± 7.1 | 85.5 ± 13.6 | .37 |
| MCV (fL) | 90.4 ± 17.5 | 98.7 ± 12 | .09 |
| ANC count × 109/L | 1.9 ± 1.5 | 2.3 ± 1.9 | .46 |
| Platelet count × 109/L | 270 ± 190 | 182 ± 148 | .07 |
| Bone marrow cellularity (%) | 68 ± 21 | 78 ± 22 | .13 |
| Bone marrow erythropoiesis (%) | 37 ± 16 | 31 ± 20 | .3 |
| Bone marrow blasts (%) | 6.9 ± 5.6 | 6.4 ± 4.6 | .73 |
| Serum ferritin (μg/L) | 515 ± 284 | 813 ± 912 | .18 |
| Serum lactate dehydrogenase | 7.0 ± 1.8 | 7.5 ± 2.8 | .56 |
| Serum erythropoietin (U/L) | 247 ± 318 | 1,293 ± 1,531 | .008 |
| S. transferrin receptor (ng/mL) | 8,667 ± 6,972 | 5,529 ± 4,632 | .07 |
| Variable . | Responding Patients, n = 18 . | Nonresponding Patients, n = 29 . | P Value . |
|---|---|---|---|
| Age (yr) | 70 ± 10 | 68 ± 10 | .6 |
| Disease duration (mo) | 10 ± 11 | 9 ± 10 | .74 |
| RBC transf. units/mo* | 2.0 ± 0.94 | 3.0 ± 1.4 | .05 |
| Hemoglobin level (g/dL) | 88.6 ± 7.1 | 85.5 ± 13.6 | .37 |
| MCV (fL) | 90.4 ± 17.5 | 98.7 ± 12 | .09 |
| ANC count × 109/L | 1.9 ± 1.5 | 2.3 ± 1.9 | .46 |
| Platelet count × 109/L | 270 ± 190 | 182 ± 148 | .07 |
| Bone marrow cellularity (%) | 68 ± 21 | 78 ± 22 | .13 |
| Bone marrow erythropoiesis (%) | 37 ± 16 | 31 ± 20 | .3 |
| Bone marrow blasts (%) | 6.9 ± 5.6 | 6.4 ± 4.6 | .73 |
| Serum ferritin (μg/L) | 515 ± 284 | 813 ± 912 | .18 |
| Serum lactate dehydrogenase | 7.0 ± 1.8 | 7.5 ± 2.8 | .56 |
| Serum erythropoietin (U/L) | 247 ± 318 | 1,293 ± 1,531 | .008 |
| S. transferrin receptor (ng/mL) | 8,667 ± 6,972 | 5,529 ± 4,632 | .07 |
*Transfusion need in the 35 patients with pretreatment RBC transfusions.